Cas:209111-67-1 N,N’-di-(n-octyl)-1,7-dibroMoperylene-3,4:9,10-tetracarboxylic acid bisiMide manufacturer & supplier

Chemical Name:N,N’-di-(n-octyl)-1,7-dibroMoperylene-3,4:9,10-tetracarboxylic acid bisiMide

CAS.NO:209111-67-1

Synonyms:N,N’-di-(n-octyl)-1,7-dibroMoperylene-3,4:9,10-tetracarboxylic acid bisiMide

Molecular Formula:C₄₀H₄₆Br₂N₆O₄

Molecular Weight:834.63904

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N,N’-di-(n-octyl)-1,7-dibroMoperylene-3,4:9,10-tetracarboxylic acid bisiMide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,N’-di-(n-octyl)-1,7-dibroMoperylene-3,4:9,10-tetracarboxylic acid bisiMide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N,N’-di-(n-octyl)-1,7-dibroMoperylene-3,4:9,10-tetracarboxylic acid bisiMide Use and application,N,N’-di-(n-octyl)-1,7-dibroMoperylene-3,4:9,10-tetracarboxylic acid bisiMide technical grade,usp/ep/jp grade.

Related News: On Friday, the US Association of Flight Attendants — which represents 50,000 flight attendants across 20 airlines — called on the government to work with airlines to discontinue all travel to China until the spread of coronavirus is contained. N,N’-di-(n-octyl)-1,7-dibroMoperylene-3,4:9,10-tetracarboxylic acid bisiMide manufacturer With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand. N,N’-di-(n-octyl)-1,7-dibroMoperylene-3,4:9,10-tetracarboxylic acid bisiMide supplier Biogen has said that some 1.5 million Americans with early-stage Alzheimer’s will be eligible for the drug, priced at an average of $56,000 per year, with the federal Medicare insurance program for seniors likely on the hook for most of the cost. N,N’-di-(n-octyl)-1,7-dibroMoperylene-3,4:9,10-tetracarboxylic acid bisiMide vendor With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand. N,N’-di-(n-octyl)-1,7-dibroMoperylene-3,4:9,10-tetracarboxylic acid bisiMide factory Biogen has said that some 1.5 million Americans with early-stage Alzheimer’s will be eligible for the drug, priced at an average of $56,000 per year, with the federal Medicare insurance program for seniors likely on the hook for most of the cost.